Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
VideoGIE ; 8(11): 464-468, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-38026705

RESUMO

Video 1Endoscopic management of Bouveret syndrome with electrohydraulic lithotripsy.

2.
J Intensive Care Soc ; 23(4): 503-505, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36751344

RESUMO

In this study we report 5-year outcomes for patients who received intermittent haemodiafiltration for Acute Kidney Injury (AKI) between 2010 and 2014 in a small Scottish Intensive Care Unit (ICU). Dialysis independence and mortality at ICU discharge, 30 and 90 days, one and five years were determined. There were 1496 admissions to ICU during the study period. 12% of patient admissions required Renal Replacement Therapy (RRT). 56.3% of patients survived to ICU discharge and all were RRT independent at ICU discharge. 30 day, 90 day, 1 year and 5 year survival was 52.3%, 50.6%, 46.6% and 30.7% respectively. By 5 years, 2 patients had developed end stage kidney disease.

3.
Expert Opin Drug Saf ; 18(3): 173-185, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30739516

RESUMO

INTRODUCTION: The use of antibiotics prenatally, during pregnancy, or neonatally may have adverse effects on the neonatal gut microbiome, and adversely affect the development of the infant immune system, leading to childhood atopy, asthma, allergy and obesity. AREAS COVERED: Vaginal eubiosis and dysbiosis from molecular-based, cultivation-independent techniques, and how this affects the neonatal gut microbiome and early development of the immune system, the association between maternal antibiotics and the beneficial role of vitamin D in the development of atopy, asthma, allergy and obesity, efforts to reduce the use of antibiotics in pregnancy and therapeutic interventions such as vaginal 'seeding', probiotics, breastfeeding and neonatal dietary supplementation. EXPERT OPINION: Currently available research gives insufficient attention to confounding variables. There remains uncertainty as to whether it is relevant that the mother suffered from the same condition as the purported infant outcome variable, for which she may have received antibiotics. In most studies, there is a lack of control for the number of antibiotic courses administered, the timing of use, the use of broad spectrum or narrow range antibiotics, the indication for antibiotics, the dose-dependent nature of the effect, the class of antibiotics used, or a varying degree of risk.


Assuntos
Antibacterianos/administração & dosagem , Microbioma Gastrointestinal/efeitos dos fármacos , Complicações Infecciosas na Gravidez/tratamento farmacológico , Animais , Antibacterianos/efeitos adversos , Asma/epidemiologia , Asma/etiologia , Criança , Feminino , Microbioma Gastrointestinal/imunologia , Humanos , Hipersensibilidade/epidemiologia , Hipersensibilidade/etiologia , Hipersensibilidade Imediata/epidemiologia , Hipersensibilidade Imediata/etiologia , Recém-Nascido , Obesidade Infantil/epidemiologia , Obesidade Infantil/etiologia , Gravidez , Efeitos Tardios da Exposição Pré-Natal/epidemiologia , Efeitos Tardios da Exposição Pré-Natal/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA